Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma

AIMS: To evaluate the expression of DSG1 and DSG2 and investigate their clinicopathological significance in EHCC. METHOD: The protein expression of DSG1 and DSG2 was measured by EnVision immunohistochemistry in 15 normal biliary tract tissues, 10 biliary tract adenoma tissues, 30 peritumoral tissues...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Anal Cell Pathol (Amst)
Prif Awduron: Xu, Shu, Huang, Shengfu, Li, Daiqiang, Zou, Qiong, Yuan, Yuan, Yang, Zhulin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi 2020
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436288/
https://ncbi.nlm.nih.gov/pubmed/32850288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9831646
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg